Design and evaluation of matrix tablets containing a natural polysaccharide as a carrier to optimize active drug's (Nsaid) absorption profile for bedtime administration (Chronotherapeutic delivery)

International Journal of Pharmaceutical Research

Volumn 2, Issue 1, 2010, Pages 52-61

  Shah, Pratik ^a   Shelat, Pragna ^a  

^a K B INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Chronotherapeutic drug delivery system (CDDS); Colon targeting; Diclofenac sodium; Guar gum; Matrix tablet

Indexed keywords

DICLOFENAC; GUAR GUM; HYDROXYPROPYLMETHYLCELLULOSE; NONSTEROID ANTIINFLAMMATORY AGENT; POLYSACCHARIDE; POVIDONE;

ANIMAL TISSUE; ARTICLE; CHRONOTHERAPY; CONTROLLED STUDY; DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG FORMULATION; DRUG GRANULATION; DRUG STABILITY; DRUG STRUCTURE; DRUG TARGETING; ENVIRONMENTAL TEMPERATURE; FAST DISSOLVING TABLET; INTESTINE TRANSIT TIME; KINETICS; MATHEMATICAL MODEL; MATRIX TABLET; NONHUMAN; PROCESS OPTIMIZATION; TABLET; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET THICKNESS;

EID: 79952081855     PISSN: None     EISSN: 09752366     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Smolensky MH, Labrecque G. Chronotherapeutics. Pharmaceutical News 1997; 4:10-16.
2. Tomolin J, Taylor JS, Read NW. The effect of mixed faecal bacteria on a selection of viscous polysaccharide in vitro. Nutr. Rep. Int.1989; 39:121-135.
3. Bayliss CE, Houston AP. Degradation of guar gum by faecal bacteria. Appl. Environ. Microbiol.1986; 48:626-632.
4. Macfarlane GT, Hay S, Macfarlane S, Gibson GR. Effect of different carbohydrates on growth polysaccharidases and glycosidase production of Bacteroides ovatus in batch and continuous culture. J. Appl. Bacteriol. 1990; 68:179-187.
5. Dario AC, Sgarbieri VC. Guar gum effects on food intake, blood serum lipids and glucose levels of Wistar rats. Plant Foods Hum. Nutr. 1998; 53:15-28.
6. Duncan CJ, Pugh N, Pasco DS, Ross SA. Isolation of a galactomannan that enhances macrophage activation from the edible fungus Morchella esculenta. J. Agric. Food Chem. 2002; 50:5683-5685.
7. Moundras C, Behr SR, Demigne A, Remesy C. Fermentable polysaccharides that enhance fecal bile acid excretion lower plasma cholesterol and apolipoprotein E-rich HDL in rats. J. Nutr. 1994; 124:2179-2188.
8. Yamatoya K, Kuwano K, Suzuki J. Effects of hydrolyzed guar gum on cholesterol and glucose in humans. Food Hydrocolloids 1997; 11:239-242.
9. http://www.guargum.info/ (accessed on 25th May, 2009)
10. Raymond CR, Paul JS, Paul JW. Handbook of Pharmaceutical Excipients. USA: American Pharmaceutical association; 4th Edition, 2003:271-273.
11. Rama Prasad YV, Krishnaiah YSR, Satyanarayana S. In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. J Control Rel, 1998; 51:281-287.
12. Krishnaiah YSR, Satyanarayana S, Rama Prasad YV, Narasimha RS. Gamma scintigraphic studies on guar gum matrix tablets for colonic drug delivery in healthy subjects. J Control Rel, 1998; 55:245-252.
13. Krishnaiah YSR, Satyanaryana S, Rama Prasad YV. Studies of guar gum compressioncoated 5-aminosalicylic acid tablets for coloncolon specific drug delivery. Drug. Dev. Ind. Pharm. 1999; 25:651-657.
14. Lachman, Herbert A. Lieberman, Joseph L. Kanig, The Theory and Practice of Industrial Pharmacy, 3rd Edition, Indian Edition. Hind Rajasthan Building, Dadar, Bombay, India: Varghese Publishing House; 1987:293-345.
15. Fatmanur TD, Sevgi T, Boyuna OK. In-vitro and In-vivo Evaluation of Mesalazine-Guar Gum Matrix Tablets for Colonic Drug Delivery Journal of Drug Targeting 2004; 12(2):105-112
16. Indian Pharmacopoeia. Government of India. Ministry of Health and Family Welfare, Published by the Indian Pharmacopoeia Commission, Ghaziabad: Volume 1, 2007:177-188.
17. Indian Pharmacopoeia. Government of India. Ministry of Health and Family Welfare, Published by the Indian Pharmacopoeia Commission, Ghaziabad: 2007; 2:1021-1022.
18. Rai G, Jain SK, Agrawal S, Pancholi SS, Agrawal GP. Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery. Pharmazie. 2005; 60:131-134.
19. Paharia A, Yadav AK, Rai G, Jain SK, Agrawal GP. Eudragit-coated Pectin Micro spheres of 5-Fluorouracil for Colon Targeting, AAPS PharmSciTech 2007; 8 (1) Article 12: E1-E7.
20. Bravo SA, Lamas MC, Salomón CJ, In-Vitro Studies of Diclofenac Sodium Controlledrelease from Biopolymeric Hydrophilic Matrices, J Pharm Pharmaceut Sci, 2002; 5(3):213-219.
21. Mooter G, Samyn C, Kinget R. The relation between swelling properties and enzymatic degradation of azo polymers designed for colon- specific drug delivery. Pharm Res. 1994; 11:1737Y1741.
22. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983; 15:25Y35.
23. Peppas NA. Analysis of Fickian and non- Fickian drug release from polymers. Pharm Acta Helv. 1985; 60:110Y112.
24. Peppas NA, Sahlin JJ. A simple equation for the description of solute release, III: coupling of diffusion and relaxation. Int J Pharm. 1989; 57:169Y175.
25. Sujja-are-evath J, Munday DL, Cox PJ, Khan KA. Release characteristics of diclofenac sodium from encapsulated natural gum minimatrix formulations. Int J Pharm. 1996;139:53-62.